ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1368	National Cancer Institute	Html	en	Breast Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for breast cancer.	Breast Screening Study-2 0.614803 breast cancer deaths 0.621624 widespread mammography screening 0.607903 biennial screening mammography 0.591767 breast cancer case 0.582361 Mammography screening rates 0.59827 meaningful breast cancer 0.581856 breast biopsy 0.585064 Breast Screening Study 0.610161 digital mammography 0.665528 breast screening 0.639247 mammography 0.707944 film mammography 0.596868 Canadian National Breast 0.584048 Nijmegen breast cancer 0.583392 breast cancer treatment 0.611216 Natl Cancer Inst 0.587118 mammography service screening 0.585616 reduces breast cancer 0.583893 Breast Cancer Diagnosis 0.59888 breast cancer therapy 0.585682 invasive breast cancer 0.614887 breast tomosynthesis screening 0.597792 women 0.639036 National Breast Screening 0.627397	early breast cancer 0.585311 increases breast cancer 0.597473 breast cancer detection 0.615948 Breast Screening Program 0.60752 breast cancer die 0.596834 late-stage breast cancer 0.587879 significant breast cancer 0.583394 breast cancers 0.586001 Digital Screening Mammography 0.598927 mammography screening 0.623635 screening mammography 0.613991 Mammography Screening Effectiveness 0.588634 digital breast tomosynthesis 0.604618 UK breast screening 0.596293 breast cancer screening 0.748635 breast cancer risk 0.584885 reduced breast cancer 0.582941 breast cancer 0.993291 clinical breast examination 0.595498 breast cancer mortality 0.853194 breast cancer cases 0.601413 breast cancer mortality. 0.607032 full-field digital mammography 0.586893 breast cancer incidence 0.622797	CLICK HERE
1448	National Cancer Institute	Html	en	Bladder and Other Urothelial Cancers Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for bladder cancer.	bladder cancers 0.459113 individual developing bladder 0.462762 bladder cancer patients 0.501836 Cancer Statistics Review 0.390961 transitional cell carcinoma 0.372436 American Cancer Society 0.389675 bladder cancer 0.911425 Bladder histological changes 0.431525 bladder cancer outcome 0.469139 bladder cancer cases 0.467655 Malignant bladder tumors 0.429947 bladder neoplasms 0.417201 bladder tumours 0.413309 repetitive hematuria screening 0.375531 bladder cancer risk 0.493294 bladder tumors 0.476533 superficial bladder cancer 0.470192 hematuria screening studies 0.380947 bladder toxicity 0.421878 Natl Cancer Inst 0.460204 newly diagnosed bladder 0.471386 Bladder Cancer Group 0.465328 metastatic bladder cancer 0.508614 neuropathic bladder 0.420139 et al. 0.424244	SEER Cancer Statistics 0.388904 bladder carcinogenesis 0.425543 bladder wall 0.415168 bladder cancer mortality 0.489217 bladder tumor antigen 0.4299 bladder cancer. 0.44027 urothelial bladder cancer 0.487451 Cancer Epidemiol Biomarkers 0.435283 urothelial cancer 0.372416 smoking related bladder 0.437945 PUBMED Abstract 0.468199 hematuria home screening 0.413339 bladder cancer case-fatality 0.488876 invasive bladder cancer 0.504621 Superficial bladder tumor 0.43348 National Cancer Institute 0.389198 Bladder cancer incidence 0.470999 bladder malignancies 0.448894 Epidemiol Biomarkers Prev 0.405245 bladder tumor incidence 0.430849 Bladder cancer screening 0.490371 Abstract 0.469966 recurrent bladder tumors 0.444789 urinary bladder cancer 0.487624	CLICK HERE
1687	National Cancer Institute	Html	en	Gastrointestinal Stromal Tumors Treatment (PDQ®)–Patient Version	Gastrointestinal stromal tumors (GIST) are usually found on the stomach or small intestine, but they can be found anywhere in or near the GI tract. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for gastrointestinal stromal tumors.	currently used treatment 0.490034 treatment 0.783421 cancer treatment 0.523117 magnetic resonance imaging 0.511967 new cancer treatments 0.495454 gastrointestinal stromal tumors 0.803015 cancer cells 0.659955 cancer spreads 0.50304 body 0.629918 imatinib mesylate 0.539824 Cancer Information Service 0.497222 treatment clinical trial 0.508389 PDQ cancer information 0.611396 specific cancer cells 0.500865 tyrosine kinase inhibitors 0.510959 treatment clinical trials 0.542788 National Cancer Institute 0.565368 clinical trials 0.968461 GISTs 0.508373 GI tract 0.557476 cancer information summary 0.563972 new treatment 0.580544 detailed pictures 0.514969 patients 0.508785	Blood. The cancer 0.489451 metastatic tumor 0.505075 following tests 0.492889 nuclear magnetic resonance 0.514044 PDQ summary 0.507052 Stromal Tumors Treatment 0.504624 PDQ Adult Treatment 0.502889 clinical trial 0.717659 malignant tumor cells 0.539522 NCI PDQ cancer 0.516596 cancer research process 0.486456 cancer clinical trials 0.513219 gastrointestinal stromal tumor 0.560708 supportive care 0.528752 Treatment Editorial Board 0.52414 treatment options 0.517296 cancer information summaries 0.495697 comprehensive cancer information 0.495617 parts 0.488573 cancer 0.897871 standard treatment 0.510757 small intestine 0.49775 watchful waiting 0.49459	CLICK HERE
1752	National Cancer Institute	Html	en	Common Moles, Dysplastic Nevi, and Risk of Melanoma	A fact sheet about moles and how some moles may be related to melanoma, the most serious type of skin cancer. Includes photos of differences between moles and cancer.	skin cancer 0.396204 new pencil eraser 0.340631 new mole 0.324515 people—have common moles 0.296925 areas 0.255107 Cancer Statistics Review 0.258106 skin surface 0.252994 American Cancer Society 0.291862 dysplastic nevi 0.760688 ABCDE features 0.255948 shape 0.300226 normal moles 0.26535 melanoma 0.905882 new moles 0.27436 distinct edge 0.298497 UV radiation 0.254044 mole look 0.348624 early melanoma 0.368768 color changes 0.261127 following changes 0.256625 moderately increased chance 0.26864 dysplastic nevus 0.99874 dark skin 0.328273 skin damage 0.265216	new colored area 0.350978 mole changes 0.343324 skin 0.706105 people—develop melanoma 0.334635 cancer cells 0.262185 sun 0.303017 atypical mole 0.288433 National Cancer Institute 0.258053 frequent skin exam 0.273598 common moles 0.677867 chance 0.337967 greater chance 0.265511 American adults—about 0.256684 surface texture 0.317122 Evolving. The mole 0.285916 people 0.632361 doctor 0.289469 normal skin tone 0.268972 family history 0.256672 early melanoma detection 0.355222 unusual mole 0.314622 common mole 0.732427 common mole look 0.339723 fair skin 0.271925	CLICK HERE
1801	National Cancer Institute	Html	es	Complicaciones orales de la quimioterapia y la radioterapia a la cabeza y el cuello (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las complicaciones orales, como la mucositis y la disfunción de la glándula salival, que se presentan en pacientes de cáncer tratados con quimioterapia y radioterapia dirigida a la cabeza y el cuello.	InfeccionesEl daño 0.516009 cáncer ayuda 0.542989 siguientes procedimientos 0.51571 células madre 0.946823 suficiente saliva 0.554388 siguientes aspectos 0.527241 sufrirán complicaciones 0.51807 siguientes elementos 0.511604 DolorEl dolor 0.547072 siguientes estrategias 0.509712 largo plazo 0.513745 Cuidado oral habitualLa 0.550733 larga duración 0.545057 efectos tardíos 0.529838 gustoLos cambios 0.518758 Saliva espesa 0.510761 dentaduras postizas 0.776994 siguientes acciones 0.53637 suficiente anticipación 0.516532 tumores benignos 0.514751	alto contenido 0.512147 PDQ Acupuntura 0.508298 dolor ayuda 0.565203 cáncer causa dolor 0.558791 paciente fuma 0.505531 siguientes problemas 0.576848 siguientes causas 0.527818 oralLa mucositis 0.525968 PDQ Fatiga 0.505245 dientes semanas 0.528906 corto plazo 0.543137 paciente trabaje 0.515322 siguientes complicaciones 0.575792 dental completo.Su odontólogo 0.538171 estrecha vigilancia 0.51193 tragarEl dolor 0.544711 rellenos dentales flojos 0.537219 paciente enfrenta situaciones 0.507967 Boca secaLa sequedad 0.620811	CLICK HERE
2056	National Cancer Institute	Html	es	Píldoras anticonceptivas y el riesgo de cáncer	Hoja informativa acerca de la investigación sobre el riesgo de padecer cáncer de seno, de cérvix, de hígado y de ovarios por el uso de anticonceptivos orales.	oral contraceptives 0.31866 associated with 0.302278 hereditary ovarian cancer 0.307224 anticonceptivos orales 0.994735 combined estrogen-progestogen 0.301637 brca1 or brca2 0.301383 Carrier Cohort Study 0.301448 Disease Control 0.30169 tumores benignos 0.304773 femeninas naturales estrógeno 0.301612 Child Health 0.30166 Steroid Hormone Study 0.30142 IARC Monographs 0.301103 collaborative reanalysis 0.302305 ovarian cancer 0.328123 IARC Working Group 0.301458 Estados Unidos 0.301544 cervical cancer 0.319583 Hormonas Esteroides 0.301394 PubMed Abstract 0.41376 menor riesgo 0.304581 hormonal factors 0.3025 BRCA2 mutation 0.301911 Ovarian Cancer Clinical 0.303961 altas concentraciones 0.302166	efecto protector 0.30213 BRCA2 mutation carriers 0.301397 anticonceptivo oral combinado” 0.302358 alto riesgo 0.304148 Carcinogenic Risks 0.301908 Hunter DJ 0.301541 oral contraception 0.301256 Endocrine-Related Cancer 0.303484 benign liver tumours 0.301157 Epidemiology Biomarkers 0.302164 Cancer Research 0.303353 epidemiological studies 0.304291 National Institute 0.301484 estrogen-progestogen menopausal therapy 0.3011 hormonal contraceptives 0.302747 Human Development 0.301691 IARC commitment 0.301082 breast cancer 0.314784 cuello uterino 0.311204 associated with oral-contraceptive 0.301437 Cancer Institute 0.303378 Colditz GA 0.301768 Combined estrogen-progestogen contraceptives 0.301471 prospective study 0.301048	CLICK HERE
3422	National Cancer Institute	Html	es	Reconstrucción del seno después de una mastectomía	Hoja informativa que describe la reconstrucción del seno (mama) después de una mastectomía. Contiene información sobre las opciones quirúrgicas, los cuidados de seguimiento y los exámenes de detección del cáncer de seno después de la reconstrucción.	cirugía abdominal 0.39888 ley whcra 0.35286 Nipple-sparing mastectomy—is it 0.332063 Cordeiro PG 0.320216 colgajo siep 0.393996 Colgajo TRAM 0.39889 suficiente piel 0.387487 largo plazo 0.34858 large cell lymphoma 0.395571 reconstruction following surgery 0.356853 Reconstructive Surgery 0.417753 Colgajo SGAP 0.397479 Colgajo PAP 0.399861 Colgajo Latissimus 0.401399 PubMed Abstract 0.945047 Colgajo TUG 0.398937 colgajo diep 0.587224 Surgical Oncology Clinics 0.338406 Cirugía oncoplástica.  0.339864 La Cruz L 0.324776 NCI titulada Mamografías 0.32023 breast reconstruction 0.705756 colgajo igap 0.469394 pequeños trozos 0.3196 suficiente tejido 0.3777	colgajos ld 0.342761 Colgajo SIEA 0.398955 Da Lio A 0.329732 implantes de solución 0.348682 reconstruction after surgery 0.366752 therapy implications following 0.337385 suficiente volumen 0.324436 reconstrucción retardada 0.559365 Breast reconstruction after 0.445489 reconstruction after mastectomy 0.350953 Petit JY 0.31974 Breast Disease 0.377661 Cancer Rights Act 0.334748 Reviews Clinical Oncology 0.3359 oncoplastic breast-conserving surgery 0.341614 Total skin sparing 0.332343 técnica llamada 0.357673 sensibilidad conforme crecen y 0.339464 anaplastic large cell 0.394345 New England Journal 0.330568 ¿qué tipo 0.325566 physical therapy 0.407423 systematic reviews 0.354768 Surgical Oncology 0.355698	CLICK HERE
3441	National Cancer Institute	Html	es	Exámenes de detección del neuroblastoma (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el neuroblastoma.	Berthold F 0.326193 mass screening 0.922436 Tuchman M 0.34781 Children may not 0.324022 neuroblastoma mortality 0.351312 Woods WG 0.492877 localized neuroblastoma detected 0.404842 Parker L 0.323694 may not benefit 0.324348 Cancer Screening 0.425638 chemical screening 0.340948 Yamamoto K 0.365979 benefit from neuroblastoma 0.405641 through mass screening 0.347656 PDQ Exámenes 0.326687 Hanada R 0.340494 mass screening system 0.350977 with neuroblastoma detected 0.349391 mass screening program 0.35097 Chamberlain J 0.321084 not benefit from 0.325375 Schilling FH 0.328231 Matsumura T 0.318421 German Neuroblastoma Screening 0.39432 with neuroblastoma 0.385081	Oncology Group study 0.324277 Neuroblastoma Cooperative Study 0.352151 Kluwer Academic Publishers 0.324031 childhood neuroblastoma death 0.391312 urinary mass screening 0.348636 Neuroblastoma mass screening 0.390256 neuroblastoma through mass 0.359101 Quebec Neuroblastoma Screening 0.468726 neuroblastoma detected 0.476634 from neuroblastoma screening 0.464226 childhood neuroblastoma 0.424072 Pediatr Hematol Oncol 0.393544 Med Pediatr Oncol 0.517922 Clin Oncol 0.429185 Neuroblastoma trends 0.350168 neuroblastoma without 0.349525 or metastatic neuroblastoma 0.348237 for screening 0.34682 Takeda T 0.332537 Pediatric Oncology Group 0.318607 Spix C 0.326336 Neuroblastoma Screening Project 0.535562 neuroblastomas detected through 0.332839 neuroblastoma screening 0.923332	CLICK HERE
16776	National Cancer Institute	Html	es	Cancell/Cantron/Protocel (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de Cancell/Cantron/Protocel como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Questionable methods 0.583285 NCI Tumor Cell 0.253187 Alternative Cancer Treatment 0.949939 Cancell Alternative Cancer 0.909029 physiological consequences 0.221271 Dills WL Jr 0.236274 Pedersen PL 0.220212 James V 0.220328 CA Cancer 0.715566 Instituto Nacional 0.460523 Tumor Cell Line 0.306478 Livingston-Wheeler therapy 0.223682 nombre cancell 0.23058 Estados Unidos 0.337461 mutational events that 0.237295 Cassileth BR 0.27252 Complementary Therapies 0.275875 tumour glycolysis 0.221381 Oncogenic alterations 0.222154 NCI-60 DTP Human 0.237422 Eastern District 0.221187 WW Norton 0.271304 Bioenerg Biomembr 0.223121 peso promedio 0.220355 District Court 0.221556	Alternative Medicine Handbook 0.357021 Edmund J 0.22088 United States 0.221128 bacteria p 0.221477 Semenza GL 0.221681 diabetes mellitus 0.223111 llamó entelev 0.224971 tipo cancell 0.228779 vía oral 0.22206 Winter Works 0.543066 Trends Biochem Sci 0.237977 critical role 0.221303 Dang CV 0.220582 Mathupala SP 0.220471 National Cancer Institute 0.327107 Aberrant glycolytic metabolism 0.237912 Permanent Injunction 0.223017 New York 0.262714 accessed april 0.557875 Cell Line Screen 0.307726 Physician Data Query 0.23188 Complete Reference Guide 0.33124 células primitivas resultantes 0.275971 Máxima concentración 0.230742	CLICK HERE
17282	National Cancer Institute	Html	es	Opciones para su atención médica si el tratamiento puede no ser una opción	Diferentes pacientes tienen metas de atención diferentes. Evalúe sus opciones de atención médica una vez se entere que tiene cáncer avanzado.	experta atención 0.942071 Palliative Care Organization 0.880871 situación mejora 0.828197	corto plazo 0.853503 sentimientos frente 0.970266	CLICK HERE